The store will not work correctly when cookies are disabled.
4-[6-Amino-5-(4-chlorophenyl)pyridin-3-yl]benzoic acid
ID: ALA4757082
PubChem CID: 162656879
Max Phase: Preclinical
Molecular Formula: C18H13ClN2O2
Molecular Weight: 324.77
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ncc(-c2ccc(C(=O)O)cc2)cc1-c1ccc(Cl)cc1
Standard InChI: InChI=1S/C18H13ClN2O2/c19-15-7-5-12(6-8-15)16-9-14(10-21-17(16)20)11-1-3-13(4-2-11)18(22)23/h1-10H,(H2,20,21)(H,22,23)
Standard InChI Key: RVAGTSXRUDWALM-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
16.1897 -1.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1886 -2.1237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8966 -2.5327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6063 -2.1232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6034 -1.3006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8948 -0.8953 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3111 -2.5300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3110 -3.3483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0186 -3.7557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7266 -3.3459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7227 -2.5245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0146 -2.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3096 -0.8893 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4355 -3.7524 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.4824 -2.5320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7747 -2.1212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0672 -2.5285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0661 -3.3466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7785 -3.7556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4831 -3.3459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3586 -3.7555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6507 -3.3473 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3591 -4.5727 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
4 7 1 0
5 13 1 0
10 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
2 15 1 0
18 21 1 0
21 22 1 0
21 23 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.77 | Molecular Weight (Monoisotopic): 324.0666 | AlogP: 4.35 | #Rotatable Bonds: 3 |
Polar Surface Area: 76.21 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.02 | CX Basic pKa: 7.02 | CX LogP: 2.38 | CX LogD: 1.86 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.75 | Np Likeness Score: -0.49 |
References
1. Dow RL,Ammirati M,Bagley SW,Bhattacharya SK,Buckbinder L,Cortes C,El-Kattan AF,Ford K,Freeman GB,Guimarães CRW,Liu S,Niosi M,Skoura A,Tess D. (2018) 2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety., 61 (7): [PMID:29570292] [10.1021/acs.jmedchem.8b00152] |